Diamox
Developed to manage glaucoma and oedema to alleviate pressure and reduce fluid retention.
Strengths: 250mg
Where to Check Availability
Medicine details
- Therapeutic class
Carbonic Anhydrase Inhibitor
- Pharmacological class
Carbonic Anhydrase Inhibitor
- Known off-label uses
altitude sickness
- Contraindications
severe hepatic impairment; severe renal impairment; hypokalaemia
- Minor side effects
nausea; dizziness; tingling in extremities
- Moderate side effects
polyuria; altered taste
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Mercury Pharma
- Onset Time
1–2 hours
- Duration
8–12 hours
- Storage instructions
Store in a cool, dry area.
- Drug interactions
topiramate; salicylates
- Age restrictions
Use requires careful clinical assessment.
- Pregnancy and breastfeeding
Pregnancy: Avoid. Breastfeeding: Low risk, but use with caution.
Precautions and warnings
may affect blood sugar control; avoid driving if drowsiness occurs; regular blood monitoring recommended
Serious side effects
stevens-johnson syndrome — requires immediate medical attention; blood dyscrasias — requires immediate medical attention
Patient summary
Developed to manage glaucoma and oedema to alleviate pressure and reduce fluid retention.
Mechanism of action
Acetazolamide is a carbonic anhydrase inhibitor. By blocking this enzyme in the eye, it reduces the production of aqueous humour, thereby lowering intraocular pressure. It also acts as a mild diuretic by inhibiting bicarbonate reabsorption.
Diamox
Developed to manage glaucoma and oedema to alleviate pressure and reduce fluid retention.
Editorial Notes
- Active ingredient(s): Acetazolamide
- Listed indication(s): Glaucoma, Oedema
Available option
- 180 tablets - 250 mg132-250-mg-2708